Coil Embolization for a Cerebral Aneurysm in a Heart Transplantation Patient: A Case Report.

Clicks: 319
ID: 105221
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
The number of heart transplantations performed in Japan has been continuously increasing. Here, we report the case of a patient with an unruptured cerebral artery aneurysm after undergoing heart transplantation and was treated using coil embolization. The patient was a 50-year-old woman who was positive for heparin-induced thrombocytopenia (HIT) antibodies and underwent heart transplantation for dilated cardiomyopathy. An unruptured middle cerebral artery aneurysm was treated with coil embolization using argatroban as a heparin substitute. The patient was discharged without any complications. Despite these patients with heart transplantation are characterized by high HIT antibodies rate and the need for immunosuppressive agents, they currently have an excellent prognosis, especially in Japan. Therefore, the knowledge of patient characteristics after heart transplantation is essential for ensuring that these patients receive the most appropriate treatment.
Reference Key
takagaki2020coilnmc Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Takagaki, Masatoshi;Nakagawa, Tomoyoshi;Kawabata, Shuhei;Izutsu, Nobuyuki;Nishida, Takeo;Nakamura, Hajime;Kishima, Haruhiko;
Journal nmc case report journal
Year 2020
DOI
10.2176/nmccrj.cr.2019-0097
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.